Abstract:Forskolin, one of the primary active metabolites of labdane-type diterpenoids, exhibits significant medicinal value, such as anticancer, antiasthmatic, and antihypertensive activities. In this study, we constructed a Saccharomyces cerevisiae cell factory that efficiently produced forskolin. First, a chassis strain that can accumulate 145.8 mg/L 13R-manoyl oxide (13R-MO), the critical precursor of forskolin, was constructed. Then, forskolin was produced by integrating CfCYP76AH15, CfCYP76AH11, CfCYP76AH16, ATR1, and CfACT1-8 into the 13R-MO chassis with a titer of 76.25 μg/L. We confirmed that cytochrome P450 enzymes (P450s) are the rate-limiting step by detecting intermediate metabolite accumulation. Forskolin production reached 759.42 μg/L by optimizing the adaptations between CfCYP76AHs, t66CfCPR, and t30AaCYB5. Moreover, multiple metabolic engineering strategies, including regulation of the target genes’ copy numbers, amplification of the endoplasmic reticulum (ER) area, and cofactor metabolism enhancement, were implemented to enhance the metabolic flow to forskolin from 13R-MO, resulting in a final forskolin yield of 21.47 mg/L in shake flasks and 79.33 mg/L in a 5 L bioreactor. These promising results provide guidance for the synthesis of other natural terpenoids in S. cerevisiae, especially for those containing multiple P450s in their synthetic pathways.Key points• The forskolin biosynthesis pathway was optimized from the perspective of system metabolism for the first time in S. cerevisiae.• The adaptation and optimization of CYP76AHs, t66CfCPR, and t30AaCYB5 promote forskolin accumulation, which can provide a reference for diterpenoids containing complex pathways, especially multiple P450s pathways.• The forskolin titer of 79.33 mg/L is the highest production currently reported and was achieved by fed-batch fermentation in a 5 L bioreactor.

Engineered Microbial Consortium for De Novo Production of Sclareolide

Efficient Biotransformation of Sclareol to Sclareolide by Filobasidium Magnum JD1025

Engineering yeast for high-level production of diterpenoid sclareol

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Construction of an Artificial Microbial Consortium for Green Production of (−)-Ambroxide

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

Engineering sub-organelles of a diploid Saccharomyces cerevisiae to enhance the production of 7-dehydrocholesterol

Enhancing Oleanolic Acid Production in Engineered Saccharomyces Cerevisiae

Improved Linalool Production in Saccharomyces Cerevisiae by Combining Directed Evolution of Linalool Synthase and Overexpression of the Complete Mevalonate Pathway

Comparative Proteomic Analyses of Hyphozyma Roseonigra ATCC 20624 in Response to Sclareol

De Novo Production of Hydroxytyrosol by Saccharomyces cerevisiae-Escherichia coli Coculture Engineering

Metabolic engineering of Yarrowia lipolytica for scutellarin production

Engineering of Saccharomyces cerevisiae for 24-Methylene-Cholesterol Production

Metabolic engineering of Saccharomyces cerevisiae for the biosynthesis of ethyl crotonate

Multi‐modular engineering of Saccharomyces cerevisiae for high‐titre production of tyrosol and salidroside

Modular Pathway Compartmentalization for Agroclavine Overproduction in Saccharomyces cerevisiae

Engineering Saccharomyces cerevisiae for enhanced (–)-α-bisabolol production

Construction and optimization of Saccharomyces cerevisiae for synthesizing forskolin

Engineering Sclareol Production on the Leaf Surface of Nicotiana tabacum

Metabolic engineering of Saccharomyces cerevisiae for chelerythrine biosynthesis

Engineering Saccharomyces cerevisiae coculture platform for the production of flavonoids.